Clinical Trial to Assess the Safety and Efficacy of Sodium Stibogluconate (SSG) and AmBisome® Combination, Miltefosine and AmBisome® and Miltefosine Alone for the Treatment Visceral Leishmaniasis in Eastern Africa
The recruitment status of this study is unknown because the information has not been verified recently.
Verified March 2011 by Drugs for Neglected Diseases. Recruitment status was Recruiting
Study NCT01067443
Information provided by Drugs for Neglected Diseases
First Received on February 10, 2010.
Last Updated on March 9, 2011
History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
